Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Breast Neoplasms 13Lung Neoplasms 9Carcinoma, Renal Cell 7Rectal Neoplasms 5Pancreatic Neoplasms 5Neoplasms 5Lymphoma 5Colorectal Neoplasms 5Colonic Neoplasms 5Uterine Cervical Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Glioblastoma 4Esophageal Neoplasms 4Breast Neoplasms, Male 4Sarcoma 3Melanoma 3Lymphoma, Large B-Cell, Diffuse 3Kidney Neoplasms 3Hodgkin Disease 3Head and Neck Neoplasms 3Esophageal Squamous Cell Carcinoma 3Brain Neoplasms 3Adenocarcinoma Of Esophagus 3Urinary Bladder Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2Thyroid Neoplasms 2Thyroid Cancer, Papillary 2Stomach Neoplasms 2Spinal Cord Neoplasms 2

Interventions

Doxorubicin 11Ifosfamide 10Radiotherapy 7pazopanib 4Imatinib Mesylate 3Filgrastim 3Etoposide 3Epirubicin 3Chemotherapy, Adjuvant 3Bevacizumab 3cixutumumab 2carotuximab 2belinostat 2Vincristine 2Sunitinib 2Sorafenib 2Radiotherapy, Conformal 2Paclitaxel 2Gemcitabine 2Dactinomycin 2Cyclophosphamide 2Carboplatin 2tremelimumab 1trebananib 1temsirolimus 1soblidotin 1romidepsin 1ribociclib 1regorafenib 1perifosine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hemangiosarcoma × Fluorodeoxyglucose F18 × Clear all
NCT01462630 2022-08-19

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

Fox Chase Cancer Center

Phase 2 Completed
29 enrolled 10 charts
Sarcoma

Hemangiosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡